Dr. John C. Reed informed Clovis Oncology, Inc. that he would resign from the Board of Directors of the company effective immediately. Dr. Reed's resignation from the Board of Directors did not result from any disagreement with the company, other directors or members of management, and was due to the time constraints and other obligations imposed by his new job as Head of Roche Pharma Research and Early Development.